Literature DB >> 22687824

Rise in the number of notified human hantavirus infections since October 2011 in Baden-Wurttemberg, Germany.

I Boone1, C Wagner-Wiening, D Reil, J Jacob, U M Rosenfeld, R G Ulrich, D Lohr, G Pfaff.   

Abstract

From October 2011 to April 2012, 852 human hantavirus infections were notified in Germany, of which 580 (68%) were in Baden-Württemberg. Case numbers started to rise earlier than they did before the previous outbreaks in 2007 and 2010, and are the largest ever reported in this state during October to April of any year. The early rise could be due to a beech mast year in 2011, followed by an early and massive reproduction of the reservoir bank vole populations during winter 2011 and spring 2012.

Entities:  

Mesh：

Year:  2012        PMID： 22687824

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  10 in total

1.  Surveillance of hantaviruses in Poland: a study of animal reservoirs and human hantavirus disease in Subcarpathia.

Authors:  Aleksander Michalski; Marcin Niemcewicz; Agata Bielawska-Drózd; Anna Nowakowska; Jerzy Gaweł; Grzegorz Pitucha; Justyna Joniec; Katarzyna Zielonka; Anna Marciniak-Niemcewicz; Janusz Kocik
Journal:  Vector Borne Zoonotic Dis       Date:  2014-06-05       Impact factor: 2.133

2.  Occurrence of immunoglobulin M antibodies against several bacterial and viral pathogens in acute hantavirus infection.

Authors:  Nele Wellinghausen; Andrea Goetz; Ursula Weber
Journal:  Clin Vaccine Immunol       Date:  2012-07-11

Review 3.  Hantaviruses as zoonotic pathogens in Germany.

Authors:  Detlev H Krüger; Rainer G Ulrich; Jörg Hofmann
Journal:  Dtsch Arztebl Int       Date:  2013-07-08       Impact factor: 5.594

4.  Recent increase in prevalence of antibodies to Dobrava-Belgrade virus (DOBV) in yellow-necked mice in Northern Italy.

Authors:  A Rizzoli; V Tagliapietra; R Rosà; H C Hauffe; G Marini; L Voutilainen; T Sironen; C Rossi; D Arnoldi; H Henttonen
Journal:  Epidemiol Infect       Date:  2015-07       Impact factor: 4.434

5.  Identification of factors influencing the Puumala virus seroprevalence within its reservoir in aMontane Forest Environment.

Authors:  Bryan R Thoma; Jörg Müller; Claus Bässler; Enrico Georgi; Anja Osterberg; Susanne Schex; Christian Bottomley; Sandra S Essbauer
Journal:  Viruses       Date:  2014-10-23       Impact factor: 5.048

6.  Association of low serum TGF-β level in hantavirus infected patients with severe disease.

Authors:  Mahmoud Sadeghi; Imad Lahdou; Jakob Ettinger; Mojdeh Heidary Navid; Volker Daniel; Martin Zeier; Jörg Hofmann; Gerhard Opelz; Paul Schnitzler
Journal:  BMC Immunol       Date:  2015-04-14       Impact factor: 3.615

7.  Clinical course and long-term outcome of hantavirus-associated nephropathia epidemica, Germany.

Authors:  Joerg Latus; Matthias Schwab; Evelina Tacconelli; Friedrich-Michael Pieper; Daniel Wegener; Juergen Dippon; Simon Müller; David Zakim; Stephan Segerer; Daniel Kitterer; Martin Priwitzer; Barbara Mezger; Birgit Walter-Frank; Angela Corea; Albrecht Wiedenmann; Stefan Brockmann; Christoph Pöhlmann; M Dominik Alscher; Niko Braun
Journal:  Emerg Infect Dis       Date:  2015-01       Impact factor: 6.883

8.  Spatial dynamics of a zoonotic orthohantavirus disease through heterogenous data on rodents, rodent infections, and human disease.

Authors:  Sophie O Vanwambeke; Caroline B Zeimes; Stephan Drewes; Rainer G Ulrich; Daniela Reil; Jens Jacob
Journal:  Sci Rep       Date:  2019-02-20       Impact factor: 4.379

9.  High infection rate of bank voles (Myodes glareolus) with Puumala virus is associated with a winter outbreak of haemorrhagic fever with renal syndrome in Croatia.

Authors:  A Tadin; L Bjedov; J Margaletic; B Zibrat; L Cvetko Krajinovic; P Svoboda; I C Kurolt; Z Stritof Majetic; N Turk; O Dakovic Rode; R Civljak; I Kuzman; A Markotic
Journal:  Epidemiol Infect       Date:  2014-01-02       Impact factor: 4.434

10.  Temporal dynamics of Puumala hantavirus infection in cyclic populations of bank voles.

Authors:  Liina Voutilainen; Eva R Kallio; Jukka Niemimaa; Olli Vapalahti; Heikki Henttonen
Journal:  Sci Rep       Date:  2016-02-18       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.